Does ELRANATAMAB Cause Covid-19 pneumonia? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Covid-19 pneumonia have been filed in association with ELRANATAMAB (Elrexfio). This represents 1.9% of all adverse event reports for ELRANATAMAB.
14
Reports of Covid-19 pneumonia with ELRANATAMAB
1.9%
of all ELRANATAMAB reports
5
Deaths
13
Hospitalizations
How Dangerous Is Covid-19 pneumonia From ELRANATAMAB?
Of the 14 reports, 5 (35.7%) resulted in death, 13 (92.9%) required hospitalization, and 3 (21.4%) were considered life-threatening.
Is Covid-19 pneumonia Listed in the Official Label?
Yes, Covid-19 pneumonia is listed as a known adverse reaction in the official FDA drug label for ELRANATAMAB.
What Other Side Effects Does ELRANATAMAB Cause?
Cytokine release syndrome (131)
Immune effector cell-associated neurotoxicity syndrome (44)
Death (42)
Pyrexia (42)
Pneumonia (40)
Cytomegalovirus infection (34)
Neutropenia (30)
Covid-19 (29)
Infection (28)
Cytomegalovirus infection reactivation (24)
What Other Drugs Cause Covid-19 pneumonia?
RITUXIMAB (1,489)
DEXAMETHASONE (758)
LENALIDOMIDE (750)
PREDNISONE (749)
OCRELIZUMAB (669)
TACROLIMUS (622)
MYCOPHENOLATE MOFETIL (594)
PREDNISOLONE (479)
METHOTREXATE (472)
CYCLOPHOSPHAMIDE (430)
Which ELRANATAMAB Alternatives Have Lower Covid-19 pneumonia Risk?
ELRANATAMAB vs ELRANATAMAB-BCMM
ELRANATAMAB vs ELTROMBOPAG
ELRANATAMAB vs ELTROMBOPAG OLAMINE
ELRANATAMAB vs ELUXADOLINE
ELRANATAMAB vs ELVITEGRAVIR